Literature DB >> 24559857

Clinical inertia, uncertainty and individualized guidelines.

G Reach1.   

Abstract

Doctors often do not follow the guidelines of good practice based on evidence-based medicine, and this "clinical inertia" may represent an impediment to efficient care. The aims of this article are as follows: 1) to demonstrate that this phenomenon is often the consequence of a discrepancy between the technical rationality of evidence-based medicine and the modes of reasoning of physicians practiced in "real-life", which is marked by uncertainty and risk; 2) to investigate in this context the meaning of the recent, somewhat paradoxical, concept of "individualized guidelines"; and 3) to revisit the real, essentially pedagogical, place of guidelines in medical practice.
Copyright © 2014. Published by Elsevier Masson SAS.

Keywords:  Clinical inertia; Emotions; Evidence-based medicine; Heuristics; Individualized guidelines; Uncertainty

Mesh:

Year:  2014        PMID: 24559857     DOI: 10.1016/j.diabet.2013.12.009

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  12 in total

1.  Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine.

Authors:  Giovanni Di Minno; Elena Tremoli
Journal:  Haematologica       Date:  2017-02-28       Impact factor: 9.941

2.  Improving access to clinical practice guidelines with an interactive graphical interface using an iconic language.

Authors:  Suzanne Pereira; Sylvain Hassler; Saliha Hamek; César Boog; Nicolas Leroy; Marie-Catherine Beuscart-Zéphir; Madeleine Favre; Alain Venot; Catherine Duclos; Jean-Baptiste Lamy
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-26       Impact factor: 2.796

3.  Simplistic and complex thought in medicine: the rationale for a person-centered care model as a medical revolution.

Authors:  Gérard Reach
Journal:  Patient Prefer Adherence       Date:  2016-04-05       Impact factor: 2.711

Review 4.  Bringing patient centricity to diabetes medication access in Canada.

Authors:  Judith L Glennie; Katharina Kovacs Burns; Paul Oh
Journal:  Clinicoecon Outcomes Res       Date:  2016-10-17

5.  Development of a complex intervention to promote appropriate prescribing and medication intensification in poorly controlled type 2 diabetes mellitus in Irish general practice.

Authors:  Mark E Murphy; Molly Byrne; Atieh Zarabzadeh; Derek Corrigan; Tom Fahey; Susan M Smith
Journal:  Implement Sci       Date:  2017-09-16       Impact factor: 7.327

6.  Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).

Authors:  Gustavo Saposnik; Angel P Sempere; Daniel Prefasi; Daniel Selchen; Christian C Ruff; Jorge Maurino; Philippe N Tobler
Journal:  Front Neurol       Date:  2017-03-01       Impact factor: 4.003

7.  Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study.

Authors:  Boon-How Chew; Husni Hussain; Ziti Akthar Supian
Journal:  BMC Fam Pract       Date:  2021-06-11       Impact factor: 2.497

8.  How much is too much? Outcomes in patients using high-dose insulin glargine.

Authors:  T Reid; L Gao; J Gill; A Stuhr; L Traylor; A Vlajnic; A Rhinehart
Journal:  Int J Clin Pract       Date:  2015-11-13       Impact factor: 2.503

9.  Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).

Authors:  Gustavo Saposnik; Angel Perez Sempere; Roula Raptis; Daniel Prefasi; Daniel Selchen; Jorge Maurino
Journal:  BMC Neurol       Date:  2016-05-04       Impact factor: 2.474

10.  Supporting general practitioner-based care for poorly controlled type 2 diabetes mellitus (the DECIDE study): feasibility study and protocol for a pilot cluster randomised controlled trial.

Authors:  Mark E Murphy; Molly Byrne; Fiona Boland; Derek Corrigan; Paddy Gillespie; Tom Fahey; Susan M Smith
Journal:  Pilot Feasibility Stud       Date:  2018-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.